RegeneRx Receives Israeli Patent for Treating and Repairing Heart Damage

RegeneRx Biopharmaceuticals, Inc, an American publicly traded, clinical-stage, biopharmaceutical company, has received an Israeli patent with claims for preventing, inhibiting or reducing heart tissue More...